53 related articles for article (PubMed ID: 22493355)
1. Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients.
Vergani E; Frigerio S; Dugo M; Devecchi A; Feltrin E; De Cecco L; Vallacchi V; Cossa M; Di Guardo L; Manoukian S; Peissel B; Ferrari A; Gallino G; Maurichi A; Rivoltini L; Sensi M; Rodolfo M
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573422
[TBL] [Abstract][Full Text] [Related]
2. Melanoma: What do all the mutations mean?
Davis EJ; Johnson DB; Sosman JA; Chandra S
Cancer; 2018 Sep; 124(17):3490-3499. PubMed ID: 29663336
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy for melanoma: a primer.
Davies MA; Gershenwald JE
Surg Oncol Clin N Am; 2011 Jan; 20(1):165-80. PubMed ID: 21111965
[TBL] [Abstract][Full Text] [Related]
4. A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines with Inducible Gene Modulation Capabilities.
Bok I; Angarita A; Douglass SM; Weeraratna AT; Karreth FA
JID Innov; 2022 Mar; 2(2):100076. PubMed ID: 35146482
[TBL] [Abstract][Full Text] [Related]
5. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
6. Screening for Mutations in Hereditary Cancer Susceptibility Genes in a Region with High Endogamy in Brazil.
Oliveira P; Correa P; Acosta A; Freitas J; Machado-Lopes T; Bomfim-Palma T; Ribeiro-Dos-Santos Â; Santos S; Nascimento R; Nascimento I; Abe-Sandes K
Glob Med Genet; 2023 Dec; 10(4):376-381. PubMed ID: 38074417
[No Abstract] [Full Text] [Related]
7. Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects.
Mun Y; Kim W; Shin D
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569558
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma.
Limm K; Dettmer K; Reinders J; Oefner PJ; Bosserhoff AK
PLoS One; 2016; 11(8):e0160348. PubMed ID: 27479139
[TBL] [Abstract][Full Text] [Related]
9. Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.
Puig-Butille JA; Escámez MJ; Garcia-Garcia F; Tell-Marti G; Fabra À; Martínez-Santamaría L; Badenas C; Aguilera P; Pevida M; Dopazo J; del Río M; Puig S
Oncotarget; 2014 Mar; 5(6):1439-51. PubMed ID: 24742402
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma and melanocortin 1 receptor.
Rosenkranz AA; Slastnikova TA; Durymanov MO; Sobolev AS
Biochemistry (Mosc); 2013 Nov; 78(11):1228-37. PubMed ID: 24460937
[TBL] [Abstract][Full Text] [Related]
11. High- and low-penetrance cutaneous melanoma susceptibility genes.
Fargnoli MC; Argenziano G; Zalaudek I; Peris K
Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
[TBL] [Abstract][Full Text] [Related]
12. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Tanami H; Imoto I; Hirasawa A; Yuki Y; Sonoda I; Inoue J; Yasui K; Misawa-Furihata A; Kawakami Y; Inazawa J
Oncogene; 2004 Nov; 23(54):8796-804. PubMed ID: 15467732
[TBL] [Abstract][Full Text] [Related]
13. Models and mechanisms in malignant melanoma.
Benjamin CL; Melnikova VO; Ananthaswamy HN
Mol Carcinog; 2007 Aug; 46(8):671-8. PubMed ID: 17570501
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of human cutaneous melanoma-derived cell lines.
Ogbah Z; Puig-Butille JA; Simonetta F; Badenas C; Cervera R; Milá J; Benitez D; Malvehy J; Vilella R; Puig S
Anticancer Res; 2012 Apr; 32(4):1245-51. PubMed ID: 22493355
[TBL] [Abstract][Full Text] [Related]
15. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
[TBL] [Abstract][Full Text] [Related]
16. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
